Aion Therapeutic Inc.

AION

CA00905T1021

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 14:35:57 31/05/2024 BST			5-day change	1st Jan Change
0.015 ^CAD	-.--%		-.--%	-25.00%

05-17	Aion Therapeutic Inc. announced that it has received CAD 0.75 million in funding	CI
04-22	Aion Therapeutic Inc. announced that it expects to receive CAD 0.75 million in funding	CI

Osoyoos Cannabis Inc. Announces Cessation of Tyler Devenyi as Chief Operating Officer

April 21, 2020 at 09:53 pm

Osoyoos Cannabis Inc. announced that effective March 31, 2020, Mr. Tyler Devenyi ceased to hold office as Chief Operating Officer of the company. Mr. Devenyi continues to serve as a director of Osoyoos.

Latest news about Aion Therapeutic Inc.

Aion Therapeutic Inc. announced that it has received CAD 0.75 million in funding	05-16	CI
Aion Therapeutic Inc. announced that it expects to receive CAD 0.75 million in funding	04-21	CI
Aion Therapeutic Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	04-02	CI
Aion Therapeutic Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	01-02	CI
Aion Therapeutic Inc. completed the acquisition of Toppen Health Inc.	12-14	CI
Aion Therapeutic Inc. entered into a definitive share purchase agreement to acquire Toppen Health Inc. for $4.9 million.	22/10/23	CI
Aion Therapeutic Inc. entered into a definitive share purchase agreement to acquire Toppen Health for $4.9 million.	22/10/23	CI
Aion Therapeutic Inc. announced that it has received CAD 0.6425 million in funding	04/10/23	CI
Aion Therapeutic Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	28/09/23	CI
Aion Therapeutic Inc. Reports Earnings Results for the Full Year Ended April 30, 2023	27/08/23	CI
Aion Therapeutic Inc. announced that it has received CAD 0.4275 million in funding	13/08/23	CI
Aion Therapeutic Announces Resignation of Rosy Mondin as Director	06/07/23	CI
Aion Therapeutic Inc. announced that it expects to receive CAD 0.5 million in funding	03/07/23	CI
Aion Therapeutic Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	03/04/23	CI
Aion Therapeutic Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	30/12/22	CI
Aion Therapeutic Inc. Reports Earnings Results for the First Quarter Ended July 31, 2022	04/11/22	CI
Aion Therapeutic Inc. Reports Earnings Results for the Full Year Ended April 30, 2022	01/11/22	CI
Aion Therapeutic Inc. Auditor Raises 'Going Concern' Doubt	31/10/22	CI
Aion Therapeutic Inc. Announces Management and Board Changes	30/06/22	CI
Aion Therapeutic Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022	02/04/22	CI
Aion Therapeutic Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2021	30/12/21	CI
Aion Therapeutic Inc. Reports Earnings Results for the First Quarter Ended July 31, 2021	02/11/21	CI
Aion Therapeutic Inc. Auditor Raises 'Going Concern' Doubt	28/10/21	CI
Aion Therapeutic Inc. Announces to Open Aion International Center for Psychedelic Psychiatry in Jamaica	14/07/21	CI
Aion Therapeutic Inc. announced that it has received CAD 1.487017 million in funding	10/06/21	CI

Chart Aion Therapeutic Inc.

Duration

Period

More charts

Company Profile

Aion Therapeutic Inc. is a Canada-based company, which operates within the health and wellness sector with a diverse portfolio of intellectual property. The Company, through its subsidiary, AI Pharmaceuticals Jamaica Limited, is engaged in research, development and treatment, as well as new therapeutic formulation discovery using data mining and artificial intelligence (AI) techniques. The Company develops healing chemical compounds from medical cannabis in combination with chemical compounds from psychedelic and edible mushrooms to treat conditions, such as cancer, depression, post-traumatic stress disorder (PTSD) and others, as well as opioid and alcohol addiction. The Company is also engaged in offering a water filtration system that incorporates mechanical filtration, membrane filtration, adsorption, silver infection control, ion exchange, and chemical additions into a three-stage water purification solution designed to meet the needs of consumers, business, and industries.

Sector

Pharmaceuticals

Calendar

26/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
AION THERAPEUTIC INC.	-25.00%	5.07M
DONG-E-E-JIAO CO.,LTD.	+37.29%	6.09B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-21.28%	4.14B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+4.52%	3.23B
TASLY PHARMACEUTICAL GROUP CO., LTD	-18.16%	2.83B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-7.70%	2.39B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+41.50%	1.9B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.05%	1.57B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-15.56%	1.55B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.62%	1.5B